<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Acta Neuropathol Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Acta Neuropathol Commun</journal-id>
      <journal-title-group>
        <journal-title>Acta Neuropathologica Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2051-5960</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24887055</article-id>
      <article-id pub-id-type="pmc">4035095</article-id>
      <article-id pub-id-type="publisher-id">127</article-id>
      <article-id pub-id-type="doi">10.1186/2051-5960-2-52</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Robinson</surname>
            <given-names>Christopher A</given-names>
          </name>
          <address>
            <email>christopher.robinson@saskatoonhealthregion.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Adiele</surname>
            <given-names>Reginald C</given-names>
          </name>
          <address>
            <email>rca478@mail.usask.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tham</surname>
            <given-names>Mylyne</given-names>
          </name>
          <address>
            <email>m.tham@usask.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lucchinetti</surname>
            <given-names>Claudia F</given-names>
          </name>
          <address>
            <email>clucchinetti@mayo.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Popescu</surname>
            <given-names>Bogdan FGh</given-names>
          </name>
          <address>
            <email>bogdan.popescu@usask.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pathology and Laboratory Medicine, Saskatoon Health Region/College of Medicine, University of Saskatchewan, 103 Hospital Drive, Saskatoon, SK S7N 0W8 Canada </aff>
        <aff id="Aff2"><label/>Department of Anatomy and Cell Biology, College of Medicine, University of Saskatchewan, 701 Queen Street, Saskatoon, SK S7N 5E5 Canada </aff>
        <aff id="Aff3"><label/>Cameco MS Neuroscience Research Center, University of Saskatchewan, Saskatoon City Hospital, 701 Queen Street, Saskatoon, SK S7K 0M7 Canada </aff>
        <aff id="Aff4"><label/>Department of Neurology, Mayo Clinic, College of Medicine, 200 First Street SW, Rochester, MN 55905 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>5</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>5</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>2</volume>
      <elocation-id>52</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>5</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Robinson et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Acute hemorrhagic leukoencephalitis (AHL) is a fulminant demyelinating disease of unknown etiology. Most cases are fatal within one week from onset. AHL pathology varies with the acuteness of disease. Hemorrhages, vessel fibrinoid necrosis, perivascular fibrin exudation, edema and neutrophilic inflammation are early features, while perivascular demyelination, microglial foci and myelin-laden macrophages appear later. Reactive astrocytosis is not present in early hemorrhagic non-demyelinated lesions, but is seen in older lesions. This case report presents the pathology of an AHL case with fulminant course and fatal outcome within 48&#xA0;hours from presentation. Severe hemorrhages, edema and neutrophilic inflammation in the absence of circumscribed perivascular demyelination affected the temporal neocortex and white matter, hippocampus, cerebellar cortex and white matter, optic chiasm, mammillary bodies, brainstem, cranial nerve roots and leptomeninges. Perivascular end-feet and parenchymal processes of astrocytes exhibited impressive swelling in haemorrhagic but non-demyelinated white matter regions. Astrocytes were dystrophic and displayed degenerating processes. Astrocytic swellings and remnants were immunoreactive for aquaporin-4, aquaporin-1 and glial fibrillary acidic protein. These morphological changes of astrocytes consistent with injury were also observed in haemorrhagic and normal appearing cortex. Our findings reinforce that perivascular demyelination is not present early in AHL. This is the first study that highlights the early and widespread astrocytic injury in the absence of demyelination in AHL, suggesting that, similarly to neuromyelitis optica and central pontine myelinolysis, demyelination in AHL is secondary to astrocyte injury.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Hurst&#x2019;s disease</kwd>
        <kwd>Aquaporin</kwd>
        <kwd>Glial fibrillary acidic protein</kwd>
        <kwd>Edema</kwd>
        <kwd>Haemorrhage</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="intro">
      <title>Introduction</title>
      <p>Acute hemorrhagic leukoencephalitis (AHL), or Hurst&#x2019;s disease, is a fulminant demyelinating disease of unknown etiology with fatal outcome within one week from onset due to severe cerebral edema and herniation 
[<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Histopathologically, AHL is characterized by the presence of perivascular haemorrhagic demyelinating lesions with prominent edema, axonal injury and predominantly neutrophilic parenchymal and meningeal inflammatory infiltrates 
[<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Based on the pathological similarities between acute disseminated encephalomyelitis (ADEM) and AHL, AHL is now considered a hyperacute variant of ADEM 
[<xref ref-type="bibr" rid="CR3">3</xref>]. In many cases, both AHL and ADEM occur within 2 to 4&#xA0;weeks of a premonitory infection, most commonly a viral upper respiratory infection, although the prerequisite of an antecedent infection is neither specific nor sensitive for their diagnosis 
[<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>The pathological features of AHL differ between acute and late disease stages 
[<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Severe hemorrhages, fibrin impregnation of blood vessel walls and perivascular fibrin exudation, edema and predominantly neutrophilic inflammation are characteristic for the early AHL stages seen in patients with fulminant disease and fatal course within 2&#xA0;days. Perivascular demyelination, perivascular microglial foci and myelin-laden macrophages appear later in the disease evolution as seen in patients with a longer disease course. Similarly, hypertrophic reactive astrocytes are not seen in early hemorrhagic non-demyelinated lesions, but may become apparent in older AHL lesions 
[<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Herein, we describe the pathology of a case of AHL with a fulminant and fatal course, and provide histopathological evidence that damage to astrocytes is an early event that precedes demyelination in AHL.</p>
      <sec id="Sec2">
        <title>Consent</title>
        <p>This study was approved by the University of Saskatchewan Biomedical Research Ethics Board (Bio-REB # 11&#x2013;217). The Bio-REB issued a waiver of the requirement of consent for the examination of retrospective archival pathological material when patient or next of kin contact was not possible due to unavailable medical records and contact information (this is a 12 year old case). All samples were deidentified. Bio-REB considered the requirements of section 29 under the Health Information Protection Act (HIPA) and was satisfied that this study meets the privacy considerations outlined therein.</p>
      </sec>
    </sec>
    <sec id="Sec3">
      <title>Case report</title>
      <p>A 39&#xA0;year old male patient presented to the ER department for new-onset seizures and severe headache preceded by three days of flu-like symptoms. A CT head was performed but revealed no abnormalities. The patient was prescribed sedatives and discharged home. The next day the patient became lethargic and slow to answer questions. Subsequently his level of consciousness deteriorated rapidly and he was found unconscious when Emergency Medical Services arrived. He was treated on site for narrow complex tachycardia (160/min) without any benefit and then transported to the ER. Neurological examination revealed deep coma (Glasgow Coma Scale 3/15) with pinpoint pupils. His general examination was remarkable for tachycardia (160/min), hypertension (214/116) and few respiratory crackles. He was intubated for airway protection. A CT scan revealed mild dilation of the ventricular temporal horns and poor grey &#x2013; white matter differentiation. A chest X-ray was suggestive of pulmonary edema. An ECG revealed atrial flutter with 2:1 block that responded to amiodarone infusion. CBC showed 17.5X10<sup>9</sup> white blood cells/L (differential not available), normal haemoglobin and platelet counts. Drug screen and blood cultures were negative. CSF examination revealed bloody fluid, with increased protein (4.66&#xA0;g/l) and 365 cells/&#x3BC;l with 75% lymphocytes and 25% polymorphonuclear leukocytes. CSF Gram stain and cultures were negative.</p>
      <p>The patient was admitted to ICU where he reverted to narrow complex tachycardia and became hypotensive. He received DC shocks multiple times and the amiodarone bolus was repeated. The patient reverted to sinus rhythm, but remained hypotensive, and IV fluids and vasopressors were administered. He continued to deteriorate, went into a ventricular rhythm and was noted to have fixed dilated pupils. Despite cardiovascular support, he became asystolic and cardiopulmonary resuscitation proved unsuccessful. The patient was pronounced dead 3&#xA0;hours after admission.</p>
      <sec id="Sec4">
        <title>Pathology</title>
        <p>At autopsy, the brain was markedly swollen and weighed 1650&#xA0;g. Gross examination revealed moderate cortical gyral flattening, and bilateral uncal and cerebellar tonsil herniation. Diffuse, spotty haemorrhages were noted in the temporal lobes, cerebellar hemispheres and brainstem. The large intracranial arteries at the base of the brain were normal in calibre and distribution, and showed no pathological changes. There was no evidence of aneurysm and no free blood in the cranial cavity. The spinal cord was unremarkable both grossly and microscopically.</p>
        <p>Brain tissue was fixed in 10&#x2013;15% formalin and embedded in paraffin. Sections, 5&#xA0;&#x3BC;m thick, were stained with haematoxylin and eosin (HE) for morphological evaluation and Luxol-fast blue- haematoxylin and eosin (LFB/HE) to demonstrate myelin. Immunohistochemistry was performed using an avidin&#x2013;biotin technique without modification 
[<xref ref-type="bibr" rid="CR9">9</xref>]. Antigen retrieval was performed as previously described. Tissues were exposed (16&#xA0;hrs, at 4&#xB0;C), to primary antibodies specific for: aquaporin-1 (AQP1; rabbit polyclonal 1:500; Santa Cruz, USA), aquaporin-4 (AQP4; affinity-purified rabbit polyclonal 1:250; Sigma-Aldrich, USA), glial fibrillary acidic protein (GFAP, mouse monoclonal 1:4000; Dako, Denmark), myelin proteolipid protein (PLP, rabbit polyclonal 1:500; Serotec, Oxford, USA), myelin oligodendrocyte glycoprotein (MOG, rabbit monoclonal 1:1000; Abcam, USA), myelin-associated glycoprotein (MAG, rabbit monoclonal 1:500; Sigma, USA), T lymphocytes (CD3, rat monoclonal 1:400; Serotec, USA), cytotoxic T lymphocytes (CD8, mouse monoclonal 1:50; Dako, Denmark), macrophages/microglial cells (CD68, mouse monoclonal 1:1000; Dako, Denmark), human immunoglobulin G (IgG, rabbit monoclonal 1:500; Epitomics, USA), herpes simplex virus 1 and 2 (HSV 1&amp;2, rabbit polyclonal 10&#xA0;mg/ml; Biocare Medical, USA) and cytomegalovirus (CMV, mouse monoclonal, 10&#xA0;mg/ml; Biocare Medical, USA). Primary antibodies were omitted in control staining. In situ hybridization was performed using fluorescein-labeled oligonucleotide probes specific for Epstein-Barr Virus-Encoded RNA (EBER; Ventana Medical Systems, USA).</p>
        <p>Microscopically, perivascular haemorrhages, involving small veins and venules preferentially, were present and abundant in the leptomeninges (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>a), neocortex and subcortical white matter of the temporal lobes (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>b), hippocampus, cerebellar cortex and white matter (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>c), optic chiasm, mammillary bodies, throughout the brainstem (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>d, f-g) and in the cranial nerve roots (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>e). Within the medulla, hemorrhages involved the floor of the fourth ventricle bilaterally, while the inferior olivary nucleus, olivocerebellar fibers, amiculum olivae and the pyramids were affected unilaterally (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>d). Ball and ring haemorrhages affected grey and white matter indiscriminately throughout the nervous system both supra- and infratentorially (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>f,g). In many instances, involved vessels showed evidence of fibrinoid necrosis and fibrin exudation (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>h). Occasionally the vessel lumen was occluded by fibrin or platelet thrombi. Moderate and marked inflammatory infiltrates were present perivascularly, within the vessel walls and parenchymally. They consisted mainly of neutrophils (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>i). Mild and moderate perivascular and parenchymal invasion with monocyte and T-lymphocyte, predominantly cytotoxic T-cells, was also present. Perivascular microglial foci were rare. Parenchymal microglial nodules were present but restricted to hemorrhagic areas (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>j). There was no evidence of perivascular immunoglobulin deposition. Neither reactive astrocytosis nor neuronal eosinophilia were present.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Neuropathology of AHL.</bold> Haemorrhages are present in the <bold>(a)</bold> leptomeninges (HE, scale bar&#x2009;=&#x2009;500&#xA0;&#x3BC;m), <bold>(b)</bold> temporal lobe (HE, scale bar&#x2009;=&#x2009;1600&#xA0;&#x3BC;m), <bold>(c)</bold> cerebellum (HE, scale bar&#x2009;=&#x2009;200&#xA0;&#x3BC;m), <bold>(d)</bold> medullary olive (LFB/HE, scale bar&#x2009;=&#x2009;500&#xA0;&#x3BC;m) and <bold>(e)</bold> vagus nerve root (LFB/HE, scale bar&#x2009;=&#x2009;100&#xA0;&#x3BC;m). <bold>(f)</bold> Ball (LFB/HE, scale bar&#x2009;=&#x2009;100&#xA0;&#x3BC;m) and <bold>(g)</bold> ring haemorrhages (LFB/HE, scale bar&#x2009;=&#x2009;100&#xA0;&#x3BC;m) affect the pontine white and gray matter, respectively. <bold>(h)</bold> An involved blood vessel shows evidence of fibrinoid necrosis and fibrin exudation (HE, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m). <bold>(i)</bold> Perivascular inflammatory infiltrates consist mainly of neutrophils (HE, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m). <bold>(j)</bold> Parenchymal microglial foci are confined to haemorrhagic areas [CD68/LFB/Nuclear Fast Red (NFR), scale bar&#x2009;=&#x2009;100&#xA0;&#x3BC;m]. <bold>(k)</bold> Myelin pallor is present in the cerebellar white matter and seems to be due to spreading of the myelin sheaths because of edema and diffusion of an eosinophilic fibrin-like substance conferring the white matter a sieve-like appearance (LFB/HE, scale bar&#x2009;=&#x2009;100&#xA0;&#x3BC;m). <bold>(l)</bold> High magnification visualization of the myelinated fibers reveals vacuolation and decompaction of myelin (arrow heads); rare apoptotic oligodendrocytes are present (arrow) (LFB/HE, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m).</p></caption><graphic xlink:href="40478_2014_127_Fig1_HTML" id="d30e416"/></fig></p>
        <p>Apart from the presence of hemorrhages, edema with tissue vacoulation was the most prominent neuropathological feature observed both at gross examination and microscopically. Myelin was well preserved and perivascular demyelination not present. Myelin pallor was present in the inferior olive and cerebellar white matter and appeared to be due to spreading of the myelin sheaths because of edema and diffusion of an eosinophilic fibrin-like substance similar to the perivascular fibrin exudates conferring the white matter a sieve-like appearance (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>k,l). Higher magnification of the myelinated fibers in these areas of myelin rarefaction revealed vacuolation and decompaction of myelin (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>l, arrowheads). Rare apoptotic oligodendrocytes were present (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>l, arrow).</p>
        <p>Astrocytes in these non-demyelinated white matter regions (Figure&#xA0;
<xref rid="Fig2" ref-type="fig">2</xref>a,c) affected by hemorrhages and perivascular fibrin exudates (Figure&#xA0;
<xref rid="Fig2" ref-type="fig">2</xref>b) displayed morphological changes consistent with injury (Figure&#xA0;
<xref rid="Fig2" ref-type="fig">2</xref>d-l). Perivascular astrocyte end-feet and parenchymal astrocyte processes exhibited impressive swelling (Figure&#xA0;
<xref rid="Fig2" ref-type="fig">2</xref>d-i). Astrocytes were dystrophic and displayed &#x201C;beaded&#x201D; processes consistent with degeneration (Figure&#xA0;
<xref rid="Fig2" ref-type="fig">2</xref>j-l). Both the astrocytic swellings and the dot-like astrocytic remnants were immunoreactive for AQP4, AQP1 and GFAP (Figure&#xA0;
<xref rid="Fig2" ref-type="fig">2</xref>d-l).<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Astrocytes in the affected white matter show morphological changes consistent with injury in the absence of demyelination. (a)</bold> Myelin is preserved in white matter regions affected by haemorrhages (PLP, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m). <bold>(b)</bold> White matter blood vessel shows perivascular fibrin exudation (also note the absence of axonal swellings consistent with absence of axonal injury) (HE, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m), but <bold>(c)</bold> perivascular myelin is preserved (PLP, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m). <bold>(d-f)</bold> Perivascular astrocyte end-feet exhibit impressive swelling: astrocytic swellings are immunoreactive for <bold>(d)</bold> AQP4 (AQP4, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m), <bold>(e)</bold> AQP1 (AQP1, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m) and <bold>(f)</bold> GFAP (scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m). <bold>(g-i)</bold> Parenchymal astrocyte processes exhibit impressive swelling: astrocytic swellings are immunoreactive for <bold>(g)</bold> AQP4 (AQP4, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m), <bold>(h)</bold> AQP1 (AQP1, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m) and <bold>(i)</bold> GFAP (scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m). <bold>(j-l)</bold> Astrocytes are dystrophic and have &#x201C;beaded&#x201D; processes consistent with degeneration: the dot-like astrocytic remnants are immunoreactive for <bold>(j)</bold> AQP4 (AQP4, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m), <bold>(k)</bold> AQP1 (AQP1, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m) and <bold>(l)</bold> GFAP (scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m).</p></caption><graphic xlink:href="40478_2014_127_Fig2_HTML" id="d30e504"/></fig></p>
        <p>Despite the presence of meningeal hemorrhage and inflammation often extending in the Virchow&#x2013;Robin spaces (Figure&#xA0;
<xref rid="Fig3" ref-type="fig">3</xref>d), tissue vacuolation, parenchymal hemorrhages and neutrophilic infiltrates, the myelin in the temporal cortex was preserved (Figure&#xA0;
<xref rid="Fig3" ref-type="fig">3</xref>e). However, protoplasmic astrocytes exhibited both swelling and degeneration of their processes and perivascular end-feet (Figure&#xA0;
<xref rid="Fig3" ref-type="fig">3</xref>a-c), and the severity of these changes decreased from the pia toward the white matter. Vacuolation of protoplasmic astrocytic processes (Figure&#xA0;
<xref rid="Fig3" ref-type="fig">3</xref>f) and perivascular end-feet (Figure&#xA0;
<xref rid="Fig3" ref-type="fig">3</xref>g), as well as GFAP-positive astrocytic swellings (Figure&#xA0;
<xref rid="Fig3" ref-type="fig">3</xref>h) were also present in the frontal cortex in the presence of meningeal inflammation, but in the absence of either perivascular or parenchymal brain tissue inflammatory infiltrates, or vasculopathy. Astrocytes in the parietal and occipital cortex displayed normal morphology (Figure&#xA0;
<xref rid="Fig3" ref-type="fig">3</xref>i-k).<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Astrocytes in the affected and non-affected cortices are injured. (a-b)</bold> Astrocyte swellings are immunoreactive for <bold>(a)</bold> AQP4 (AQP4, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m)) and <bold>(b)</bold> AQP1 (AQP1, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m). <bold>(c)</bold> Degenerated astrocyte processes are immunoreactive for GFAP (GFAP, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m). <bold>(d)</bold> Meningeal haemorrhages and inflammation extend into the perivascular spaces and upper cortical layers (HE, scale bar&#x2009;=&#x2009;200&#xA0;&#x3BC;m); inset shows neutrophils infiltrating into the molecular layer of the cortex (HE, scale bar&#x2009;=&#x2009;8.75&#xA0;&#x3BC;m). <bold>(e)</bold> Cortical myelin is preserved in regions affected by haemorrhage (PLP, scale bar&#x2009;=&#x2009;100&#xA0;&#x3BC;m). <bold>(f-g)</bold> Astrocytes in the frontal cortex which does not show haemorrhages or vascular changes have <bold>(f)</bold> swollen processes (AQP4, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m) and <bold>(g)</bold> swollen perivascular end-feet (AQP4, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m). <bold>(h)</bold> Astrocyte swellings in the frontal cortex also display GFAP immunoreactive swellings (GFAP, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m). <bold>(i-k)</bold> Normal morphology of astrocytes in the occipital cortex of this case: <bold>(i)</bold> parenchymal astrocytes (AQP4, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m); <bold>(j)</bold> perivascular astrocytes (AQP4, scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m); and <bold>(k)</bold> astrocytic fibers (GFAP, scale bar&#x2009;=&#x2009;33&#xA0;&#x3BC;m).</p></caption><graphic xlink:href="40478_2014_127_Fig3_HTML" id="d30e581"/></fig></p>
        <p>Tissue stains for microorganisms, including HSV, EBV, CMV and fungi were negative. No viruses were isolated in the CSF collected at necropsy and the cryptococcal antigen test was negative.</p>
        <p>Microscopic examination of the myocardium of the left ventricle and posterior wall of the right ventricle revealed the presence of polymorphonuclears, predominantly perivascularly. There was no evidence of necrosis, fibrosis or damage to the vessel wall, and no evidence of damage to the myocytes. Sections of the lungs revealed pulmonary edema, and there was acute congestion of the liver. Examination of other organs and tissues reveled no pathological changes.</p>
      </sec>
    </sec>
    <sec id="Sec5" sec-type="discussion">
      <title>Discussion</title>
      <p>While haemorrhagic perivascular demyelination is considered the histopathologic hallmark of AHL, previous studies have shown that the pathology of AHL varies with the acuteness of the disease 
[<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. The predominance and severity of haemorrhages and edema, and the preponderance of neutrophils in inflammatory infiltrates we have found in this case coupled with the absence of frank perivascular demyelination, the absence of macrophages and the rarity of perivascular microglial infiltrates are acute histopathological features consistent with the short interval between onset and death in AHL 
[<xref ref-type="bibr" rid="CR6">6</xref>], and similar to what is observed in AHL experimental models 
[<xref ref-type="bibr" rid="CR10">10</xref>]. In cases with a longer course, increasing proportions of macrophages and microglia are found in the inflammatory infiltrates, and perivascular demyelination may become obvious 
[<xref ref-type="bibr" rid="CR6">6</xref>]. Our findings corroborated with previously published studies reinforce the concept that disease stage influences AHL pathology: circumscribed perivascular demyelination is not present in fulminant cases with fatal outcome within 1 to 2&#xA0;days from onset.</p>
      <p>This is the first study that highlights the early and widespread injury of astrocytes in AHL. We show that both protoplasmic and fibrous astrocytes exhibit swelling of their end-feet and degeneration of their processes and cell bodies in the absence of demyelination and considerable oligodendrocyte injury, suggesting that astrocytes may be an early initial target in AHL and that demyelination is secondary. These findings may also explain the absence of reactive astrocytosis seen in this case, and other reported acute AHL cases 
[<xref ref-type="bibr" rid="CR8">8</xref>]. While we show that astrocytes are the first nervous cells affected in AHL, it is possible that primary vasculopathy with secondary tissue destruction-related neutrophil infiltration and vasogenic edema causes astrocytic injury.</p>
      <p>However, we also found astrocytes with swollen processes and perivascular end-feet in cortical regions without hemorrhages, brain tissue inflammation or vascular changes. This reinforces the early astrocytic disturbance in AHL that may be independent of the presence of vascuolpathy, and raises interesting questions regarding the chronology of lesion development. Morphological changes of astrocytes similar to those described here have been reported in cytotoxic edema associated with hyponatremia, ischemia, brain trauma and hepatic encephalopathy 
[<xref ref-type="bibr" rid="CR11">11</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>]. Furthermore, imaging studies have shown that decreased apparent diffusion coefficient consistent with cytotoxic edema is present in AHL before the blood&#x2013;brain barrier (BBB) is altered 
[<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. All these findings show an important early role for cytotoxic edema in AHL and suggest that hypoxic, osmotic or toxic stress may drive the pathogenesis of this idiopathic disorder and/or render these central nervous system (CNS) regions more susceptible to BBB damage, free entry of blood toxins or autoantibodies, and development of lesions 
[<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>Meningeal inflammation is a constant pathological finding in ADEM and AHL 
[<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>], and is the earliest histopathological feature observed in experimental allergic encephalomyelitis (EAE) and hyperacute EAE 
[<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], preceding the appearance of parenchymal inflammation and demyelination. Furthermore, we show that the upper cortical layers located in close proximity to the haemorrhagic and inflamed leptomeninges exhibit severe astrocytic fragmentation, while the further located deep cortical layers only show astrocyte swelling. It is therefore plausible that the cytotoxic swelling of astrocytes with or without breakdown of BBB may be caused by toxic products released by neutrophils and other inflammatory cells that have infiltrated the subarachnoid space 
[<xref ref-type="bibr" rid="CR19">19</xref>], and suggest a potential beneficial role for neutrophil-depletion therapies in AHL 
[<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>].</p>
      <p>Both neuromyelitis optica (NMO) and central pontine myelinolysis (CPM) are primary astrocytopathies with secondary demyelination 
[<xref ref-type="bibr" rid="CR21">21</xref>&#x2013;<xref ref-type="bibr" rid="CR23">23</xref>]. NMO is an autoimmune inflammatory astrocytopathy caused by anti-AQP4 complement-activating IgG autoantibodies 
[<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], while astrocytic injury in CPM is a consequence of the osmotic stress 
[<xref ref-type="bibr" rid="CR22">22</xref>]. Early lesions in both NMO and a subgroup of CPM patients are characterized by astrocytic damage, and loss of AQP4 in NMO and of both AQP4 and AQP1 in CPM 
[<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. The BBB is altered in both NMO (required for the entry of the pathogenic autoantibodies into the CNS) and CPM (caused by endothelial shrinkage due to the rapid correction of chronic hypotonicity with a hyperosmolar solution). Loss of AQP4 in NMO is caused by its internalization by astrocytes or by complement-mediated destruction of astrocytes following binding of NMO-IgG to AQP4 
[<xref ref-type="bibr" rid="CR26">26</xref>], while loss of AQP4 and AQP1 in CPM may represent a protective mechanism whereby astrocytes restrict water loss to prevent apoptosis 
[<xref ref-type="bibr" rid="CR22">22</xref>]. The disruption of the BBB coupled with the inability of astrocytes to either buffer or eliminate the excess water in NMO and CPM causes vasogenic edema and increased osmolarity of the CNS extracellular space and may trigger and/or exacerbate the intramyelinic edema, oligodendrocyte apoptosis and secondary demyelination. Early AHL lesions exhibit preservation of AQP4 and AQP1. Aquaporins represent the rate-limiting step for water flow from the vascular compartment into the CNS 
[<xref ref-type="bibr" rid="CR27">27</xref>]. Therefore, the preservation of AQP1 and AQP4 allows astrocytes to initially buffer the water that flows from the blood into the CNS through an intact BBB likely due to hypoosmolality or hypoxic energy failure that causes cytotoxic edema 
[<xref ref-type="bibr" rid="CR27">27</xref>]. However, in the presence of a persisting insult, the compensatory mechanisms ultimately fail and the swollen astrocytes die 
[<xref ref-type="bibr" rid="CR28">28</xref>].</p>
      <p>In conclusion, we present a case of AHL with rapid progression and fatal outcome within less than 48&#xA0;hours from onset, whose neuropathologic picture is dominated by the widespread swelling and degeneration of astrocytes in the absence of demyelination, suggesting that, similarly to NMO and CPM, demyelination in AHL is secondary to astrocyte injury.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>Dr. Robinson, Dr. Adiele and Ms. Tham have no conflict of interest.</p>
        <p>Dr. Lucchinetti may accrue revenue for a patent re: Aquaporin-4 associated antibodies for diagnosis of neuromyelitis optica; receives royalties from the publication of Blue Books of Neurology: Multiple Sclerosis 3 (Saunders Elsevier, 2010); and receives research support from the NIH (NS49577-R01; principal investigator), the Guthy Jackson Charitable Foundation (principal investigator), and the National MS Society (RG 3185 B-3; principal investigator).</p>
        <p>Dr. Popescu served as a speaker for Teva Innovation Canada, received honorarium for publishing in Continuum, received research support from the Saskatchewan Health Research Foundation (principal investigator) and receives research support from the Canada Research Chairs program (principal investigator).</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>BFP, CAR, RCA, MT and CFL analyzed and interpreted the immunohistological data. CAR performed the CNS pathology and collected the available clinical data. BFP and CAR interpreted the clinical data. CAR and BFP conceived this study. BFP, CAR and CFL drafted the manuscript. All authors edited, read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors thank Anita Givens, University Saskatchewan for her expert technical assistance and the Department of Pathology and Lab Medicine, Saskatoon Health Region for retrieval of tissue blocks, and performance of HSV and CMV IHC, and EBER ISH. R.C.A. and M.T. are Fellows in the Canadian Institutes of Health Research Training grant in Health Research Using Synchrotron Techniques (CIHR-THRUST). M.T. is supported by a College of Medicine Graduate Scholarship, University of Saskatchewan and a Saskatchewan Innovation and Opportunity Scholarship, Government of Saskatchewan. This work was supported by the Saskatchewan Health Research Foundation (to B.F.P.) and the Canada Research Chairs program (to B.F.P.).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hart</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Earle</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1975</year>
          <volume>38</volume>
          <issue>6</issue>
          <fpage>585</fpage>
          <lpage>591</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.38.6.585</pub-id>
          <pub-id pub-id-type="pmid">239102</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hurst</surname>
              <given-names>EW</given-names>
            </name>
          </person-group>
          <article-title>Acute haemorrhagic leucoencephalitis: a previously undefied entity</article-title>
          <source>Med J Aust</source>
          <year>1941</year>
          <volume>28</volume>
          <fpage>1</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Russell</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>The nosological unity of acute haemorrhagic leucoencephalitis and acute disseminated encephalomyelitis</article-title>
          <source>Brain</source>
          <year>1955</year>
          <volume>78</volume>
          <issue>3</issue>
          <fpage>369</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/78.3.441</pub-id>
          <pub-id pub-id-type="pmid">13269597</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenlee</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Encephalitis and postinfectious encephalitis</article-title>
          <source>Continuum</source>
          <year>2012</year>
          <volume>18</volume>
          <issue>6</issue>
          <fpage>1271</fpage>
          <lpage>1289</lpage>
          <pub-id pub-id-type="pmid">23221841</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Weinshenker</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Lucchinetti</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Acute disseminated encephalomyelitis: current understanding and controversies</article-title>
          <source>Semin Neurol</source>
          <year>2008</year>
          <volume>28</volume>
          <issue>1</issue>
          <fpage>84</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2007-1019130</pub-id>
          <pub-id pub-id-type="pmid">18256989</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gosztoni</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Acute haemorrhagic leucoencephalitis. Report of three cases</article-title>
          <source>Z Neurol</source>
          <year>1973</year>
          <volume>204</volume>
          <issue>1</issue>
          <fpage>43</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">4121503</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamarche</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Behan</surname>
              <given-names>PO</given-names>
            </name>
            <name>
              <surname>Segarra</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Recurrent acute necrotizing hemorrhagic encephalopathy</article-title>
          <source>Acta Neuropathol</source>
          <year>1972</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>79</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00687552</pub-id>
          <pub-id pub-id-type="pmid">5083841</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adams</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Cammermeyer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Denny-Brown</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Acute necrotizing hemorrhagic encephalopathy</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>1949</year>
          <volume>8</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1097/00005072-194901000-00001</pub-id>
          <pub-id pub-id-type="pmid">18108331</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vass</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lassmann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wekerle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wisniewski</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis</article-title>
          <source>Acta Neuropathol</source>
          <year>1986</year>
          <volume>70</volume>
          <issue>2</issue>
          <fpage>149</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00691433</pub-id>
          <pub-id pub-id-type="pmid">3488634</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levine</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wenk</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>A hyperacute form of allergic encephalomyelitis</article-title>
          <source>Am J Pathol</source>
          <year>1965</year>
          <volume>47</volume>
          <fpage>61</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">14308139</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosoi</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Brain edema in acute liver failure and chronic liver disease: similarities and differences</article-title>
          <source>Neurochem Int</source>
          <year>2013</year>
          <volume>62</volume>
          <issue>4</issue>
          <fpage>446</fpage>
          <lpage>457</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuint.2013.01.015</pub-id>
          <pub-id pub-id-type="pmid">23376027</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaur</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sivakumar</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-induced astrocytic reaction and increased vascular permeability in the rat cerebellum</article-title>
          <source>Glia</source>
          <year>2006</year>
          <volume>54</volume>
          <issue>8</issue>
          <fpage>826</fpage>
          <lpage>839</lpage>
          <pub-id pub-id-type="doi">10.1002/glia.20420</pub-id>
          <pub-id pub-id-type="pmid">16977604</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pasantes-Morales</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vazquez-Juarez</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Transporters and channels in cytotoxic astrocyte swelling</article-title>
          <source>Neurochem Res</source>
          <year>2012</year>
          <volume>37</volume>
          <issue>11</issue>
          <fpage>2379</fpage>
          <lpage>2387</lpage>
          <pub-id pub-id-type="doi">10.1007/s11064-012-0777-2</pub-id>
          <pub-id pub-id-type="pmid">22544664</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Electron microscope studies of cerebral swelling. 3. Alterations in the neuroglia and the blood vessels of the white matter</article-title>
          <source>Acta Neuropathol</source>
          <year>1965</year>
          <volume>4</volume>
          <issue>6</issue>
          <fpage>624</fpage>
          <lpage>639</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00691213</pub-id>
          <pub-id pub-id-type="pmid">5886837</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Na</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Serial MR imaging findings of acute hemorrhagic leukoencephalitis: a case report</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2005</year>
          <volume>26</volume>
          <issue>8</issue>
          <fpage>1996</fpage>
          <lpage>1999</lpage>
          <pub-id pub-id-type="pmid">16155148</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mader</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Wolff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Niemann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kuker</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Acute haemorrhagic encephalomyelitis (AHEM): MRI findings</article-title>
          <source>Neuropediatrics</source>
          <year>2004</year>
          <volume>35</volume>
          <issue>2</issue>
          <fpage>143</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2004-817906</pub-id>
          <pub-id pub-id-type="pmid">15127316</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levine</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Hyperacute, neutrophilic, and localized forms of experimental allergic encephalomyelitis: a review</article-title>
          <source>Acta Neuropathol</source>
          <year>1974</year>
          <volume>28</volume>
          <issue>3</issue>
          <fpage>179</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00719023</pub-id>
          <pub-id pub-id-type="pmid">4139872</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waksman</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit</article-title>
          <source>Am J Pathol</source>
          <year>1962</year>
          <volume>41</volume>
          <fpage>135</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">14004485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiga</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Onodera</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kogure</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamasaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yashima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Syozuhara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sendo</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Neutrophil as a mediator of ischemic edema formation in the brain</article-title>
          <source>Neurosci Lett</source>
          <year>1991</year>
          <volume>125</volume>
          <issue>2</issue>
          <fpage>110</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="doi">10.1016/0304-3940(91)90003-C</pub-id>
          <pub-id pub-id-type="pmid">1881586</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moxon-Emre</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schlichter</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Neutrophil depletion reduces blood&#x2013;brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2011</year>
          <volume>70</volume>
          <issue>3</issue>
          <fpage>218</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="doi">10.1097/NEN.0b013e31820d94a5</pub-id>
          <pub-id pub-id-type="pmid">21293296</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lucchinetti</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Popescu</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Fujihara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Itoyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Misu</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica</article-title>
          <source>Brain Pathol</source>
          <year>2014</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>83</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="doi">10.1111/bpa.12099</pub-id>
          <pub-id pub-id-type="pmid">24345222</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popescu</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Bunyan</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Parisi</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lennon</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Lucchinetti</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Evidence of aquaporin involvement in human central pontine myelinolysis</article-title>
          <source>Acta Neuropathol Commun</source>
          <year>2013</year>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>40</fpage>
          <pub-id pub-id-type="doi">10.1186/2051-5960-1-40</pub-id>
          <pub-id pub-id-type="pmid">24252214</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roemer</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Parisi</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lennon</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Benarroch</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Lassmann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bruck</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Mandler</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Weinshenker</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Pittock</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Wingerchuk</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Lucchinetti</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis</article-title>
          <source>Brain</source>
          <year>2007</year>
          <volume>130</volume>
          <issue>Pt 5</issue>
          <fpage>1194</fpage>
          <lpage>1205</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awl371</pub-id>
          <pub-id pub-id-type="pmid">17282996</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lennon</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Kryzer</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Pittock</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Verkman</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Hinson</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel</article-title>
          <source>J Exp Med</source>
          <year>2005</year>
          <volume>202</volume>
          <issue>4</issue>
          <fpage>473</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.20050304</pub-id>
          <pub-id pub-id-type="pmid">16087714</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinshenker</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Wingerchuk</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Pittock</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Lucchinetti</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Lennon</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <article-title>NMO-IgG: a specific biomarker for neuromyelitis optica</article-title>
          <source>Dis Markers</source>
          <year>2006</year>
          <volume>22</volume>
          <issue>4</issue>
          <fpage>197</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="doi">10.1155/2006/586306</pub-id>
          <pub-id pub-id-type="pmid">17124341</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hinson</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Popescu</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Lucchinetti</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Fryer</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Wolburg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fallier-Becker</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Noell</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lennon</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <article-title>Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2012</year>
          <volume>109</volume>
          <issue>4</issue>
          <fpage>1245</fpage>
          <lpage>1250</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1109980108</pub-id>
          <pub-id pub-id-type="pmid">22128336</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saadoun</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Papadopoulos</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Aquaporin-4 in brain and spinal cord oedema</article-title>
          <source>Neuroscience</source>
          <year>2010</year>
          <volume>168</volume>
          <issue>4</issue>
          <fpage>1036</fpage>
          <lpage>1046</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.08.019</pub-id>
          <pub-id pub-id-type="pmid">19682555</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szatkowski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Attwell</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms</article-title>
          <source>Trends Neurosci</source>
          <year>1994</year>
          <volume>17</volume>
          <issue>9</issue>
          <fpage>359</fpage>
          <lpage>365</lpage>
          <pub-id pub-id-type="doi">10.1016/0166-2236(94)90040-X</pub-id>
          <pub-id pub-id-type="pmid">7529438</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
